Legal
Filter News
Found 6,833 articles
-
A tangled web has been woven at Michigan-based Rockwell Medical. The board of directors has fired the chief executive officer and chief financial officer.
-
A Los Angeles jury sided with 68-year-old Joanne Anderson, who was diagnosed with mesothelioma allegedly linked to a Johnson & Johnson talc product. It is the second similar award regarding the product.
-
MabVax Therapeutics Receives Nasdaq Notification Due to Late Form 10-Q
5/24/2018
MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, announced today that, as expected, the Company received notice from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1)
-
Perrigo Confirms Patent Challenge For Generic Version Of Sernivo® Spray, 0.05%
5/24/2018
Perrigo Company plc (NYSE; TASE: PRGO) announced today that Promius Pharma, LLC initiated patent litigation on May 22, 2018.
-
Omeros Announces Settlement of Infringement Suit Against ANDA Filer Lupin
5/24/2018
Lupin Confirms Validity of OMIDRIA Patents
-
Two months after a setback in the U.S. House of Representatives, Congress has authorized “right to try” legislation.
-
A former Valeant Pharmaceuticals and a former Philidor Rx Services have been found guilty of using a kickback scheme to defraud the company.
-
FDA takes action against the use of OTC benzocaine teething products due to serious safety risk, lack of benefit
5/23/2018
Agency urges companies to discontinue teething products, include new warnings for other OTC benzocaine products and revise warnings for approved prescription local anesthetic drugs
-
Webcast Alert: Ionis Pharmaceuticals Provides Corporate Update at 2018 Annual Meeting of Stockholders
5/23/2018
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present a general corporate update in conjunction with its 2018 Annual Meeting of Stockholders and Open House on Wednesday, May 23 at 2:10 p.m. Pacific Time (5:10 p.m. Eastern Time) in Carlsbad, CA.
-
ReCor Medical Announces RADIANCE-HTN SOLO Hypertension Study Meets Primary Efficacy Endpoint, Pivotal Study Submission, and New Principal Investigator
5/23/2018
ReCor Medical announced today that the RADIANCE-HTN SOLO study met its primary efficacy endpoint and demonstrated a statistically significant reduction in blood pressure in hypertensive patients.
-
NanoSomiX, Inc. Announces Issuance of First US Patent
5/22/2018
NanoSomiX, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the company's first patent covering its groundbreaking proprietary exosome isolation and biomarker detection technology.
-
FDA warns companies selling illegal, unapproved kratom products marketed for opioid cessation, pain treatment and other medical uses
5/22/2018
The U.S.Food and Drug Administration (FDA) has issued warning letters to three marketers and distributors of kratom products.
-
NanoViricides Files Quarterly Report for Period Ending March 31, 2018; Company Has Over A Year's Worth of Cash in Hand, and It Is Scaling Up Production of Certain Herpecide Program Drug Candidates
5/22/2018
NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform (the "Company"), filed its quarterly report for its third quarter of financial year 2018.
-
Evotec and Celgene Enter into Strategic Oncology Partnership
5/22/2018
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that Evotec and Celgene Corporation ("Celgene") have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology.
-
Motus GI Announces Issuance of Chinese Patent for the Pure-Vu® System
5/21/2018
- Company successfully continues to expand global IP portfolio to support strategic pathway for Pure-Vu® System to become standard of care
-
Medical Malpractice Verdict Seen as Powerful Message to Mental Health Providers
5/21/2018
The $2 million verdict on Wed, May 16, 2018 in favor of him and his wife, Marianne, as a result of the death of their son Mark, is a decision that will send a powerful and important message to the psychiatric community.
-
Nox Medical Achieves Success in Patent Infringement Lawsuit
5/21/2018
Nox Medical has achieved a major success in its case alleging that Natus Neurology willfully infringed Nox Medical's patent covering the biometric connector on its disposable RIP belts.
-
HedgePath Pharmaceuticals Announces Additional Expanded Patent Coverage
5/21/2018
HPPI's patent portfolio expands again with claims covering treatment of any non-cancerous proliferation disorders with itraconazole, the active ingredient in HPPI's current and anticipated future product candidates
-
coreHEM Publishes Core Outcome Set for Hemophilia Clinical Trials; Prepares to Launch Next Phase of Work
5/21/2018
The coreHEM initiative has announced the publication of a core outcome set for clinical trials of gene therapy in hemophilia.
-
Minnesota Protects Patients with New Step Therapy Bill
5/21/2018
National Psoriasis Foundation Leads Effort to Pass Step Therapy Reform